We are live on ! Find out more
DARE icon

Dare Bioscience
DARE

24 hedge funds and large institutions have $2.39M invested in Dare Bioscience in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 3

0.57% more ownership

Funds ownership: 8.93% → 9.51% (+0.57%)

1% less capital invested

Capital invested by funds: $2.43M → $2.39M (-$34.9K)

4% less funds holding

Funds holding: 25 → 24 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
24
Holders Change
-1
Holders Change %
-4%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
8
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$123K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$54.6K
3
AE
AMH Equity
New York
+$44.4K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$10.1K
5
Renaissance Technologies
Renaissance Technologies
New York
+$5.9K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$51.7K
2
UBS Group
UBS Group
Switzerland
-$32K
3
TRCT
Tower Research Capital (TRC)
New York
-$602
4
JP Morgan Chase
JP Morgan Chase
New York
-$6

DARE Hedge Fund Activity: Q1 2025 in Review

24 of the 7,473 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q1 2025, worth a combined $2.39M — down 1.4% from $2.43M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of DARE and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 8 added.

The largest buyer was Vanguard Group, adding an estimated $123K. The largest seller was Jane Street, exiting entirely with an estimated $51.7K sold.

  • 24 institutional investors held Dare Bioscience (DARE) as of Q1 2025, down from 25 in Q4 2024.
  • Funds reported $2.39M of Dare Bioscience stock for Q1 2025, down 1.4% quarter-over-quarter.
  • 0 funds opened new Dare Bioscience positions in Q1 2025 and 1 closed out, a net change of -1 holder.
  • The largest Dare Bioscience buyer in Q1 2025 was Vanguard Group, an estimated $123K added.
  • The largest Dare Bioscience seller in Q1 2025 was Jane Street, an estimated $51.7K sold.

Based on aggregated 13F filings for Q1 2025.